Due to its minimal size and lack of bacterial backbone sequences, minicircle (MC) DNA presents a promising alternative to plasmid DNA (pDNA) for non-viral gene delivery in terms of biosafety and improved gene transfer. Here, luciferase pDNA (pCMV-luc) and analogous MC DNA (MC07.CMV-luc) were formulated into polyplexes with c-Met targeted, PEG-shielded sequence-defined oligoaminoamides, or linear PEI (linPEI) as standard transfection agent. Distinct physicochemical and biological characteristics were observed for polyplexes formed with either pDNA or MC DNA as vectors. The carriers were found to dominate the shape of polyplexes, whereas the DNA type was decisive for the nanoparticle size. c-Met-targeted, tyrosine trimer-containing polyplexes were optimized into compacted rod structures with a size of 65–100 nm for pDNA and 35–40 nm for MC. Notably, these MC polyplexes display a lack of cell cycle dependence of transfection and a ∼200-fold enhanced gene transfer efficiency in c-Met-positive DU145 prostate carcinoma cultures over their tyrosine-free pDNA analogues.
Get full access to this article
View all access options for this article.
References
1.
TrimbleCL, MorrowMP, KraynyakKA, et al.Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled Phase 2b trial. Lancet, 2015; 386:2078–2088.
KranzLM, DikenM, HaasH, et al.Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature, 2016; 534:396–401.
4.
WaltherW, SchmeerM, KobeltD, et al.A seven-year storage report of good manufacturing practice-grade naked plasmid DNA: stability, topology, and in vitro/in vivo functional analysis. Hum Gene Ther Clin Dev, 2013; 24:147–153.
5.
LächeltU, WagnerE. Nucleic acid therapeutics using polyplexes: a journey of 50 years (and beyond). Chem Rev, 2015; 115:11043–11078
6.
HardeeCL, Arevalo-SolizLM, HornsteinBD, et al.Advances in non-viral DNA vectors for gene therapy. Genes (Basel), 2017; 8:65.
7.
ZhangP, WagnerE. History of polymeric gene delivery systems. Top Curr Chem (Cham), 2017; 375:26.
PackDW, HoffmanAS, PunS, et al.Design and development of polymers for gene delivery. Nat Rev Drug Discov, 2005; 4:581–593.
10.
YinH, KanastyRL, EltoukhyAA, et al.Non-viral vectors for gene-based therapy. Nat Rev Genet, 2014; 15:541–555.
11.
RejmanJ, OberleV, ZuhornIS, et al.Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J, 2004; 377:159–169.
12.
LechardeurD, VerkmanAS, LukacsGL. Intracellular routing of plasmid DNA during non-viral gene transfer. Adv Drug Deliv Rev, 2005; 57:755–767.
13.
VaughanEE, DeanDA. Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol Ther, 2006; 13:422–428.
14.
HoekstraD, RejmanJ, WasunguL, et al.Gene delivery by cationic lipids: in and out of an endosome. Biochem Soc Trans, 2007; 35:68–71.
15.
ReillyMJ, LarsenJD, SullivanMO. Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus. Mol Pharm, 2012; 9:1280–1290.
16.
VacikJ, DeanBS, ZimmerWE, et al.Cell-specific nuclear import of plasmid DNA 927. Gene Ther, 1999; 6:1006–1014.
17.
BrunnerS, SauerT, CarottaS, et al.Cell cycle dependence of gene transfer by lipoplex, polyplex and recombinant adenovirus. Gene Ther, 2000; 7:401–407.
18.
BrunnerS, FurtbauerE, SauerT, et al.Overcoming the nuclear barrier: cell cycle independent nonviral gene transfer with linear polyethylenimine or electroporation. Mol Ther, 2002; 5:80–86.
19.
GrandinettiG, ReinekeTM. Exploring the mechanism of plasmid DNA nuclear internalization with polymer-based vehicles. Mol Pharm, 2012; 9:2256–2267.
20.
GrandinettiG, SmithAE, ReinekeTM. Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?. Mol Pharm, 2012; 9:523–538.
21.
RemautK, SymensN, LucasB, et al.Cell division responsive peptides for optimized plasmid DNA delivery: the mitotic window of opportunity?. J Control Release, 2014; 179:1–9.
22.
AndersenH, ParhamifarL, HunterAC, et al.AFM visualization of sub-50 nm polyplex disposition to the nuclear pore complex without compromising the integrity of the nuclear envelope. J Control Release, 2016; 244:24–29.
23.
KhalilIA, KogureK, AkitaH, et al.Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev, 2006; 58:32–45.
24.
HsuCY, UludagH. Effects of size and topology of DNA molecules on intracellular delivery with non-viral gene carriers. BMC Biotechnol, 2008; 8:23.
25.
AkitaH, KuriharaD, SchmeerM, et al.Effect of the compaction and the size of DNA on the nuclear transfer efficiency after microinjection in synchronized cells. Pharmaceutics, 2015; 7:64–73.
26.
CollJL, CholletP, BrambillaE, et al.In vivo delivery to tumors of DNA complexed with linear polyethylenimine. Hum Gene Ther, 1999; 10:1659–1666.
27.
ZouSM, ErbacherP, RemyJS, et al.Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med, 2000; 2:128–134.
28.
NeubergP, KichlerA. Recent developments in nucleic acid delivery with polyethylenimines. Adv Genet, 2014; 88:263–288.
29.
SchaffertD, BadgujarN, WagnerE. Novel Fmoc-polyamino acids for solid-phase synthesis of defined polyamidoamines. Org Lett, 2011; 13:1586–1589.
30.
SchaffertD, TroiberC, SalcherEE, et al.Solid-phase synthesis of sequence-defined T-, i-, and U-shape polymers for pDNA and siRNA delivery. Angew Chem Int Ed Engl, 2011; 50:8986–8989.
31.
SchaffertD, TroiberC, WagnerE. New sequence-defined polyaminoamides with tailored endosomolytic properties for plasmid DNA delivery. Bioconjug Chem, 2012; 23:1157–1165.
32.
TroiberC, EdingerD, KosP, et al.Stabilizing effect of tyrosine trimers on pDNA and siRNA polyplexes. Biomaterials, 2013; 34:1624–1633.
33.
LächeltU, KosP, MicklerFM, et al.Fine-tuning of proton sponges by precise diaminoethanes and histidines in pDNA polyplexes. Nanomedicine, 2014; 10:35–44.
34.
KosP, LächeltU, HerrmannA, et al.Histidine-rich stabilized polyplexes for cMet-directed tumor-targeted gene transfer. Nanoscale, 2015; 7:5350–5362.
35.
KleinPM, MüllerK, GutmannC, et al.Twin disulfides as opportunity for improving stability and transfection efficiency of oligoaminoethane polyplexes. J Control Release, 2015; 205:109–119.
36.
HeD, MüllerK, Krhac LevacicA, et al.Combinatorial optimization of sequence-defined oligo(ethanamino)amides for folate receptor-targeted pDNA and siRNA delivery. Bioconjug Chem, 2016; 27:647–659.
37.
HaaseR, MagnussonT, SuB, et al.Generation of a tumor- and tissue-specific episomal non-viral vector system. BMC Biotechnol, 2013; 13:49.
38.
WongSP, ArgyrosO, HarbottleRP. Sustained expression from DNA vectors. Adv Genet, 2015; 89:113–152.
39.
WongSP, HarbottleRP. Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors. Mol Ther Nucleic Acids, 2013; 2:e115.
40.
WongSP, ArgyrosO, HoweSJ, et al.Systemic gene transfer of polyethylenimine (PEI)-plasmid DNA complexes to neonatal mice. J Control Release, 2011; 150:298–306.
41.
U.S. Department of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research. Guidance for human somatic cell therapy and gene therapy. Hum Gene Ther, 2001; 12:303–314.
42.
DarquetAM, CameronB, WilsP, et al.A new DNA vehicle for nonviral gene delivery: supercoiled minicircle. Gene Ther, 1997; 4:1341–1349.
43.
StenlerS, BlombergP, SmithCI. Safety and efficacy of DNA vaccines: plasmids vs. minicircles. Hum Vaccin Immunother, 2014; 10:1306–1308.
44.
ChenZY, HeCY, EhrhardtA, et al.Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther, 2003; 8:495–500.
45.
ChenZY, HeCY, KayMA. Improved production and purification of minicircle DNA vector free of plasmid bacterial sequences and capable of persistent transgene expression in vivo. Hum Gene Ther, 2005; 16:126–131.
46.
KayMA, HeCY, ChenZY. A robust system for production of minicircle DNA vectors. Nat Biotechnol, 2010; 28:1287–1289.
47.
ChabotS, OrioJ, SchmeerM, et al.Minicircle DNA electrotransfer for efficient tissue-targeted gene delivery. Gene Ther, 2013; 20:62–68.
48.
DarquetAM, RangaraR, KreissP, et al.Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther, 1999; 6:209–218.
49.
ZhaoJ, YangL, HuangP, et al.Synthesis and characterization of low molecular weight polyethyleneimine-terminated Poly(beta-amino ester) for highly efficient gene delivery of minicircle DNA. J Colloid Interf Sci, 2016; 463:93–98.
50.
Gracey ManiarLE, ManiarJM, ChenZY, et al.Minicircle DNA vectors achieve sustained expression reflected by active chromatin and transcriptional level. Mol Ther, 2013; 21:131–138.
51.
BiggerBW, TolmachovO, CollombetJM, et al.An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J Biol Chem, 2001; 276:23018–23027.
52.
ZhangC, GaoS, JiangW, et al.Targeted minicircle DNA delivery using folate-poly(ethylene glycol)-polyethylenimine as non-viral carrier. Biomaterials, 2010; 31:6075–6086.
53.
KobeltD, SchleefM, SchmeerM, et al.Performance of high quality minicircle DNA for in vitro and in vivo gene transfer. Mol Biotechnol, 2013; 53:80–89.
54.
WanQ, XieL, GaoL, et al.Self-assembled magnetic theranostic nanoparticles for highly sensitive MRI of minicircle DNA delivery. Nanoscale, 2013; 5:744–752.
55.
KeeneyM, OngSG, PadillaA, et al.Development of poly(beta-amino ester)-based biodegradable nanoparticles for nonviral delivery of minicircle DNA. ACS Nano, 2013; 7:7241–7250.
56.
ChangTY, ChungCY, ChuangWM, et al.Durable expression of minicircle DNA-liposome-delivered androgen receptor cDNA in mice with hepatocellular carcinoma. Biomed Res Int, 2014; 2014:156356.
57.
GasparVM, GoncalvesC, de Melo-DiogoD, et al.Poly(2-ethyl-2-oxazoline)-PLA-g-PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics. J Control Release, 2014; 189:90–104.
58.
WangQT, JiangW, ChenYH, et al.In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses. J Virol, 2014; 88:1924–1934.
59.
GasparVM, BarilP, CostaEC, et al.Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin. J Control Release, 2015; 213:175–191.
60.
GasparV, de Melo-DiogoD, CostaE, et al.Minicircle DNA vectors for gene therapy: advances and applications. Expert Opin Biol Ther, 2015; 15:353–379.
61.
ZhaoJ, HuangP, WangZY, et al.Synthesis of amphiphilic poly(beta-amino ester) for efficiently minicircle DNA delivery in vivo. ACS Appl Mater Interfaces, 2016; 8:19284–19290.
62.
MunyeMM, TagalakisAD, BarnesJL, et al.Minicircle DNA provides enhanced and prolonged transgene expression following airway gene transfer. Sci Rep-Uk, 2016; 6.
63.
ScholzC, WagnerE. Therapeutic plasmid DNA versus siRNA delivery: common and different tasks for synthetic carriers. J Control Release, 2012; 161:554–565.
64.
KwokA, HartSL. Comparative structural and functional studies of nanoparticle formulations for DNA and siRNA delivery. Nanomedicine, 2011; 7:210–219.
65.
SchaffertD, KissM, RödlW, et al.Poly(I:C)-mediated tumor growth suppression in EGF-receptor overexpressing tumors using EGF-polyethylene glycol-linear polyethylenimine as carrier. Pharm Res, 2011; 28:731–741.
66.
MorysS, WagnerE, LächeltU. From artificial amino acids to sequence-defined targeted oligoaminoamides. Methods Mol Biol, 2016; 1445:235–258.
67.
KaiserE, ColescottRL, BossingerCD, et al.Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem, 1970; 34:595–598.
68.
MorysS, Krhac LevacicA, UrnauerS, et al.Influence of defined hydrophilic blocks within oligoaminoamide copolymers: compaction versus shielding of pDNA nanoparticles. Polymers, 2017; 9:142.
69.
KimEM, ParkEH, CheongSJ, et al.In vivo imaging of mesenchymal–epithelial transition factor (c-Met) expression using an optical imaging system. Bioconjug Chem, 2009; 20:1299–1306.
70.
BrodaE, MicklerFM, LächeltU, et al.Assessing potential peptide targeting ligands by quantification of cellular adhesion of model nanoparticles under flow conditions. J Control Release, 2015; 213:79–85.
71.
KimEM, ParkEH, CheongSJ, et al.Characterization, biodistribution and small-animal SPECT of I-125-labeled c-Met binding peptide in mice bearing c-Met receptor tyrosine kinase-positive tumor xenografts. Nucl Med Biol, 2009; 36:371–378.
72.
UrnauerS, MorysS, Krhac LevacicA, et al.Sequence-defined cMET/HGFR-targeted polymers as gene delivery vehicles for the theranostic sodium iodide symporter (NIS) gene. Mol Ther, 2016; 24:1395–1404.
73.
BlessingT, RemyJS, BehrJP. Template oligomerization of DNA-bound cations produces calibrated nanometric particles. J Am Chem Soc, 1998; 120:8519–8520.
74.
DeRoucheyJ, WalkerGF, WagnerE, et al.Decorated rods: a “bottom-up” self-assembly of monomolecular DNA complexes. J Phys Chem B, 2006; 110:4548–4554.
75.
TockaryTA, OsadaK, MotodaY, et al.Rod-to-globule transition of pDNA/PEG-Poly(l-Lysine) polyplex micelles induced by a collapsed balance between DNA rigidity and PEG crowdedness. Small, 2016; 12:1193–1200.
76.
BurkeRS, PunSH. Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem, 2008; 19:693–704.
MauckschC, BohlaA, HoffmannF, et al.Transgene expression of transfected supercoiled plasmid DNA concatemers in mammalian cells. J Gene Med, 2009; 11:444–453.
79.
OgrisM, SteinleinP, KursaM, et al.The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther, 1998; 5:1425–1433.
80.
LiN, ZhaiY, OberleyTD. Two distinct mechanisms for inhibition of cell growth in human prostate carcinoma cells with antioxidant enzyme imbalance. Free Radical Biol Med, 1999; 26:1554–1568.
81.
PlaticaM, IonescuA, IvanE, et al.PAR, a protein involved in the cell cycle, is functionally related to chromosomal passenger proteins. Int J Oncol, 2011; 38:777–785.
82.
RiuE, GrimmD, HuangZ, et al.Increased maintenance and persistence of transgenes by excision of expression cassettes from plasmid sequences in vivo. Hum Gene Ther, 2005; 16:558–570.
83.
ChenZY, RiuE, HeCY, et al.Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther, 2008; 16:548–556.
84.
LuJ, ZhangF, XuS, et al.The extragenic spacer length between the 5′ and 3′ ends of the transgene expression cassette affects transgene silencing from plasmid-based vectors. Mol Ther, 2012; 20:2111–2119.
85.
LuJ, ZhangF, FireAZ, et al.Sequence-modified antibiotic resistance genes provide sustained plasmid-mediated transgene expression in mammals. Mol Ther, 2017; 25:1187–1198.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
